A physiological model for autonomic heart rate regulation in human endotoxemia

Shock

Volumn 35, Issue 3, 2011, Pages 229-239

  Foteinou, Panagiota T ^a   Calvano, Steve E ^b   Lowry, Stephen F ^b   Androulakis, Ioannis P ^a  

^a RUTGERS UNIVERSITY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

autonomic nervous system; heart; humans; infection; inflammation; Mathematical modeling

Indexed keywords

ENDOTOXIN;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; ENDOTOXEMIA; HEART RATE; HUMAN; INFLAMMATION; LOW DRUG DOSE; MORBIDITY; NONHUMAN; PHENOTYPE;

AUTONOMIC NERVOUS SYSTEM; ENDOTOXEMIA; HEART RATE; HUMANS; MODELS, THEORETICAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TACHYCARDIA;

EID: 79952163506     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318200032b     Document Type: Article

References (34)

1. Cavaillon JM, Annane D: Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 12:151-170, 2006. (Pubitemid 47487521)
2. Bone RC: Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 125:680-687, 1996. (Pubitemid 126450605)
3. Sharshar T, Hopkinson NS, Orlikowski D, Annane D: Science review: the brain in sepsisVculprit and victim. Crit Care 9:37-44, 2005. (Pubitemid 40246769)
4. Tracey KJ: The inflammatory reflex. Nature 420:853-859, 2002. (Pubitemid 36019638)
5. Taub DD: Neuroendocrine interactions in the immune system. Cell Immunol 252:1-6, 2008.
6. Zaza A, Lombardi F: Autonomic indexes based on the analysis of heart rate variability: a view from the sinus node. Cardiovasc Res 50:434-442, 2001. (Pubitemid 32480237)
7. Lombardi F: Clinical implications of present physiological understanding of HRV components. Card Electrophysiol Rev 6:245-249, 2002. (Pubitemid 35282407)
8. Lowry SF, Calvano SE: Challenges for modeling and interpreting the complex biology of severe injury and inflammation. J Leukoc Biol 83:553-557, 2008. (Pubitemid 351966864)
9. Lowry SF: Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock 24(suppl 1):94-100, 2005.
10. Lowry SF: The stressed host response to infection: the disruptive signals and rhythms of systemic inflammation. Surg Clin North Am 89:311-326, 2009.
11. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP: In silico simulation of corticosteroids effect on an NFkB-dependent physicochemical model of systemic inflammation. PLoS One 4:e4706, 2009.
12. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP: Modeling endotoxininduced systemic inflammation using an indirect response approach. Math Biosci 217:27-42, 2009.
13. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP: A multi-scale model for the assessment of autonomic dysfunction in human endotoxemia. Physiol Genomics 42:5-19, 2010.
14. Jan BU, Coyle SM, Oikawa LO, Lu SE, Calvano SE, Lehrer PM, Lowry SF: Influence of acute epinephrine infusion on endotoxin-induced parameters of heart rate variability: a randomized controlled trial. Ann Surg 249:750-756, 2009.
15. Alvarez SM, Katsamanis Karavidas M, Coyle SM, Lu SE, Macor M, Oikawa LO, Lehrer PM, Calvano SE, Lowry SF: Low-dose steroid alters in vivo endotoxin-induced systemic inflammation but does not influence autonomic dysfunction. J Endotoxin Res 13:358-368, 2007.
16. Santos AA, Wilmore DW: The systemic inflammatory response: perspective of human endotoxemia. Shock 6(suppl 1):S50-S56, 1996. (Pubitemid 126727796)
17. Andreasen AS, Krabbe KS, Krogh-Madsen R, Taudorf S, Pedersen BK, Moller K: Human endotoxemia as a model of systemic inflammation. Curr Med Chem 15:1697-1705, 2008.
18. Warner HR, Cox A: A mathematical model of heart rate control by sympathetic and vagus efferent information. J Appl Physiol 17:349-355, 1962.
19. Grassi G, Esler M: How to assess sympathetic activity in humans. J Hypertens 17:719-734, 1999. (Pubitemid 29322156)
20. Glick G, Braunwald E: Relative roles of the sympathetic and parasympathetic nervous systems in the reflex control of heart rate. Circ Res 16:363-375, 1965.
21. Rittirsch D, Flierl MA, Ward PA: Harmful molecular mechanisms in sepsis. Nat Rev Immunol 8:776-787, 2008.
22. Davos CH, Davies LC, Piepoli M: The effect of baroreceptor activity on cardiovascular regulation. Hell J Cardiol 43:143-155, 2002.
23. Perlstein I, Stepensky D, Krzyzanski W, Hoffman A: A signal transduction pharmacodynamic model of the kinetics of the parasympathomimetic activity of low-dose scopolamine and atropine in rats. J Pharm Sci 91:2500-2510, 2002. (Pubitemid 35379408)
24. Contreras M, Ryan LM: Fitting nonlinear and constrained generalized estimating equations with optimization software. Biometrics 56:1268-1271, 2000.
25. van der Poll T: Effects of catecholamines on the inflammatory response. Sepsis 4:159-167, 2000.
26. Vedder H, Schreiber W, Yassouridis A, Gudewill S, Galanos C, Pollmacher T: Dose-dependence of bacterial lipopolysaccharide (LPS) effects on peak response and time course of the immune-endocrine host response in humans. Inflamm Res 48:67-74, 1999. (Pubitemid 29110233)
27. Munford RS: Severe sepsis and septic shock: the role of gram-negative bacteremia. Annu Rev Pathol Mech Dis 1:467-496, 2006.
28. Cook S, Togni M, Schaub MC, Wenaweser P, Hess OM: High heart rate: a cardiovascular risk factor? Eur Heart J 27:2387-2393, 2006. (Pubitemid 44522142)
29. Barber AE, Coyle SM, Marano MA, Fischer E, Calvano SE, Fong Y, Moldawer LL, Lowry SF: Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 150:1999-2006, 1993. (Pubitemid 23129678)
30. Santman FW: Catecholamines in critical care. The commonly used catecholamines: receptor and clinical profile, indications and dosages. Pharm Weekbl Sci 14:290-296, 1992.
31. Dunser MW, Hasibeder WR: Vasopressin in vasodilatory shock: ensure organ blood flow, but take care of the heart! Crit Care 10:172, 2006.
32. Dunser MW, Hasibeder WR: Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med 24:293-316, 2009.
33. Briegel J, Kellermann W, Forst H, Haller M, Bittl M, Hoffmann GE, Buchler M, Uhl W, Peter K: Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group. Clin Investig 72:782-787, 1994. (Pubitemid 24327776)
34. Goldstein DS, Eisenhofer G, Kopin IJ: Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther 305:800-811, 2003. (Pubitemid 36617954)